1. Home
  2. CIG vs KRYS Comparison

CIG vs KRYS Comparison

Compare CIG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comp En De Mn Cemig ADS

CIG

Comp En De Mn Cemig ADS

HOLD

Current Price

$2.00

Market Cap

5.8B

Sector

Utilities

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$282.63

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIG
KRYS
Founded
1952
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CIG
KRYS
Price
$2.00
$282.63
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$244.20
AVG Volume (30 Days)
3.4M
308.5K
Earning Date
03-19-2026
02-18-2026
Dividend Yield
13.09%
N/A
EPS Growth
N/A
275.72
EPS
0.26
6.66
Revenue
$7,960,960,695.00
$373,164,000.00
Revenue This Year
N/A
$36.14
Revenue Next Year
N/A
$42.38
P/E Ratio
$8.36
$43.80
Revenue Growth
9.92
54.51
52 Week Low
$1.59
$122.80
52 Week High
$2.30
$295.98

Technical Indicators

Market Signals
Indicator
CIG
KRYS
Relative Strength Index (RSI) 46.73 72.43
Support Level $1.95 $245.68
Resistance Level $2.04 $295.98
Average True Range (ATR) 0.04 10.96
MACD -0.00 3.09
Stochastic Oscillator 32.14 77.89

Price Performance

Historical Comparison
CIG
KRYS

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: